A7R	Ala-Thr-Trp-Leu-Pro-Pro-Arg peptide
AAT	Anti-Angiogenic Therapy
ADME	administration, distribution, metabolism, excretion
Ahx	6-aminohexanoic acid
Alloc	Allyloxycarbonyl group
Boc	Tert-butyloxycarbonyl group
BSA	Bovine Serum Albumin
CendR	C-End-Rule
Cys	Cysteine
DR7A	DArg-DPro-DPro-DLeu-DTrp-DThr-DAla peptide
Dab	2,4-Diaminobutyric Acid
DCM	Dichloromethane
DIC	N,N’-Di(propan-2-yl)methanediimine
DMF	N,N-Dimethylformamide
DOTA	2,2′,2″,2″-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl) tetraacetic acid
DOTA-tris(tBu)-NHS	tri-tert-butyl 2,2′,2″-(10-(2-((2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
ECL	Enhanced chemiluminescence
ELISA	Enzyme-Linked Immunosorbent Assay
ESI-MS	Electrospray ionization mass spectrometry analyses
Et3N	Triethylamine
Fmoc	9-fluorenylmethoxycarbonyl group
hArg	Homoarginine
HCl	Hydrogen chloride
His	Histidine
HOBt	1H-1,2,3-Benzotriazol-1-ol
HS	Human serum
IC50	Half maximal inhibitory concentration
K4R	Lys(hArg)-Dab-Pro-Arg peptidomimetic
logP	Decimal logarithm of partition coefficient
m/z	Mass-to-charge ratio
NRP-1	Neuropilin-1
NS	Negative control
P	Partition coefficient
P	Positive control
Pbf	Pentamethyl-2,3-dihydrobenzofuran-5-sulfonyl group
PBS	Phosphate-buffered saline
PET	Positron Emission Tomography
PhOH	Phenol
PTFE	Polytetrafluoroethylene membrane microfilter
R/KXXR/K	Amino acid sequence containing: R-Arginine, K-Lysine, X- any amino acid
RP-HPLC	Reverse-Phase High Pressure Liquid Chromatography
RT	Retention time
S	Measured signal
SD	Standard Deviation
SPPS	Solid Phase Peptide Synthesis
t1/2	Radionuclide half-life time
tBu	Tert-butyl group
TFA	Trifluoroacetic acid
TIPS	Tri(propan-2-yl)silane
TRNT	Targeted Radionuclide Therapy
VEGF	Vascular Endothelial Growth Factor
VEGF-A165	Vascular Endothelial Growth Factor-A165
VEGFR-2	Vascular Endothelial Growth Factor Receptor 2
β+ Emax	Beta emitter with a maximum energy
(bt)-VEGF-A165	Biotinylated VEGF-A165
(p,n)	Proton-neutron nuclear reaction